Are standard-dose and low-dose NOACs for stroke prevention more effective and safer in Asian patients compared to non-Asian patients with nonvalvular atrial fibrillation?
Standard-dose NOACs appear to offer greater efficacy and safety benefits in Asian patients compared to non-Asian patients with nonvalvular atrial fibrillation.
Our findings suggest that standard-dose NOACs were more effective and safer in Asians than in non-Asians, whereas low-dose NOACs performed similarly in both populations.
Wang et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: